BioNTech says Thank You
As a system-relevant company, Greiner Bio-One produces laboratory articles that play an important role in Sars-CoV-2 diagnostics as well as in vaccine research and production. Like many other pharmaceutical companies, BioNTech also relies on Greiner Bio-One products for the development of a Covid-19 vaccine and uses, for example, its 15- and 50-ml tubes, serological pipettes, freezing storage tubes and microplates.
Heinz Schmid and Jakob Breuer, managing directors of Greiner Bio-One GmbH Germany, pass on their thanks to their employees: "This once again underlines how important our products are in researching and combating the corona virus. We can be justifiably proud of the contribution we are making with our products to overcoming the crisis."
Read the press release from BioNTech here.